Drugs / Triamicinolone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06985537 | Jun 2025 → Jan 2026 overdue | granulomatous mastitis | Assiut University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triamicinolone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06985537 ↗ |
| Known as | Triamicinolone as (epirelefan ) (ciscortine) | “Triamicinolone as (epirelefan ) (ciscortine)” NCT06985537 ↗ |